---
figid: PMC9661889__FPHAR_fphar-2022-1021216_wc_sch6
pmcid: PMC9661889
image_filename: FPHAR_fphar-2022-1021216_wc_sch6.jpg
figure_link: /pmc/articles/PMC9661889/figure/sch6/
number: SCHEME 6
figure_title: ''
caption: Plausible mechanistic pathway for the synthesis of pyrido[2,3-d]pyrimidine-diones.
article_title: 'Synthetic approaches to potent heterocyclic inhibitors of tuberculosis:
  A decade review.'
citation: Upala Dasmahapatra, et al. Front Pharmacol. 2022;13:1021216.
year: '2022'

doi: 10.3389/fphar.2022.1021216
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- tuberculosis
- heterocycles
- synthesis
- in vitro
- Mycobacterium tuberculosis
- docking

---
